Russell Investments Group Ltd. lifted its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 66.9% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,028 shares of the medical instruments supplier’s stock after purchasing an additional 5,625 shares during the period. Russell Investments Group Ltd.’s holdings in West Pharmaceutical Services were worth $1,326,000 as of its most recent SEC filing.

Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of West Pharmaceutical Services by 6.5% in the 1st quarter. Vanguard Group Inc. now owns 6,440,844 shares of the medical instruments supplier’s stock worth $525,637,000 after purchasing an additional 392,516 shares during the period. BlackRock Inc. lifted its position in shares of West Pharmaceutical Services by 8,884.7% in the 1st quarter. BlackRock Inc. now owns 5,805,036 shares of the medical instruments supplier’s stock worth $473,749,000 after purchasing an additional 5,740,426 shares during the period. JPMorgan Chase & Co. lifted its position in shares of West Pharmaceutical Services by 10.1% in the 1st quarter. JPMorgan Chase & Co. now owns 2,031,582 shares of the medical instruments supplier’s stock worth $165,798,000 after purchasing an additional 186,692 shares during the period. Bank of New York Mellon Corp lifted its position in shares of West Pharmaceutical Services by 3.5% in the 1st quarter. Bank of New York Mellon Corp now owns 842,316 shares of the medical instruments supplier’s stock worth $68,742,000 after purchasing an additional 28,302 shares during the period. Finally, Alliancebernstein L.P. lifted its position in shares of West Pharmaceutical Services by 0.3% in the 1st quarter. Alliancebernstein L.P. now owns 840,899 shares of the medical instruments supplier’s stock worth $68,626,000 after purchasing an additional 2,748 shares during the period. 91.25% of the stock is owned by hedge funds and other institutional investors.

West Pharmaceutical Services, Inc. (NYSE WST) traded up 2.42% during midday trading on Friday, hitting $91.43. 690,209 shares of the stock traded hands. The firm’s 50-day moving average is $87.56 and its 200-day moving average is $88.98. West Pharmaceutical Services, Inc. has a 52-week low of $70.17 and a 52-week high of $99.91. The company has a market cap of $6.77 billion, a price-to-earnings ratio of 39.24 and a beta of 1.13.

West Pharmaceutical Services (NYSE:WST) last posted its quarterly earnings results on Thursday, July 27th. The medical instruments supplier reported $0.66 EPS for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. The firm had revenue of $397.60 million for the quarter, compared to analysts’ expectations of $406 million. West Pharmaceutical Services had a net margin of 11.42% and a return on equity of 14.02%. The business’s revenue for the quarter was up 2.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.59 earnings per share. Analysts predict that West Pharmaceutical Services, Inc. will post $2.68 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, November 1st. Stockholders of record on Wednesday, October 18th will be issued a $0.14 dividend. The ex-dividend date is Tuesday, October 17th. This is a boost from West Pharmaceutical Services’s previous quarterly dividend of $0.13. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.61%. West Pharmaceutical Services’s dividend payout ratio is presently 22.22%.

TRADEMARK VIOLATION NOTICE: This news story was originally published by Daily Political and is the property of of Daily Political. If you are reading this news story on another domain, it was stolen and republished in violation of US & international trademark and copyright laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/09/10/west-pharmaceutical-services-inc-wst-shares-bought-by-russell-investments-group-ltd.html.

Several research firms have recently commented on WST. Jefferies Group LLC reaffirmed a “hold” rating and issued a $90.00 target price on shares of West Pharmaceutical Services in a research report on Thursday, June 8th. Zacks Investment Research raised shares of West Pharmaceutical Services from a “hold” rating to a “strong-buy” rating and set a $114.00 target price for the company in a research report on Friday, June 9th. Finally, BidaskClub cut shares of West Pharmaceutical Services from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, June 13th. Two research analysts have rated the stock with a sell rating, one has issued a hold rating and two have given a buy rating to the stock. The stock has an average rating of “Hold” and a consensus target price of $90.18.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc is a manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. The Company’s products include vial containment solutions, prefillable systems, self-injection platforms, cartridge systems and components, reconstitution and transfer systems, intradermal delivery solutions, specialty components, and contract manufacturing and analytical services.

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services, Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services Inc. and related companies with MarketBeat.com's FREE daily email newsletter.